Clinical Trial Update: To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults [Phase 1]

View source ↗

Summary

Hyundai Pharm is conducting a Phase 1 study to evaluate the safety and pharmacokinetic interaction between HODO-22251 and HODO-22252 in healthy adults. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• HODO-22251
• HODO-22252

Snippet

Sponsor: Hyundai Pharm | Conditions: Type 2 Diabetes, Dyslipidemias | Phase 1 | Status: RECRUITING